FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036756141> ?p ?o ?g. }

• W3036756141 endingPage "5885" @default.
• W3036756141 startingPage "5879" @default.
• W3036756141 abstract "To evaluate whether autologous cytokine-induced killer (CIK) cell immunotherapy improves the prognosis of patients with high-risk diffuse large B cell lymphoma (DLBCL) after the first complete remission (CR).Peripheral blood mononuclear cells (PBMCs) were extracted from 20 patients with high-risk DLBCL (IPI≥3) after the first CR. Twenty CR patients who were age- and sex-matched during the same period were selected as controls. PBMCs were cultured with IFN-γ, IL-2 and anti-CD3 mAb to generate CIK cells. These obtained cells were then transfused back into the patients; the transfusion was repeated every 3 months up to a total of four courses. Changes in peripheral blood lymphocyte subgroups and survival were assessed.Compared with the baseline proportions, the proportion of CD3+ T cells, CD3+CD8+ T cells, and NK cells in the peripheral blood were significantly higher after transfusions (p<0.05). The 5-year DFS was improved from 45.0 ± 11.1% to 79.3 ± 9.2% in the CIK group (HR favoring CIK, 0.29; 95% CI, 0.09 to 0.92; p = 0.035), and the 5-year OS was estimated at 90 ± 6.7% for CIK versus 55 ± 11.1% for control (HR favoring CIK, 0.20; 95% CI, 0.04 to 0.93; p = 0.040). No severe side effects were observed related to CIK treatment.Autologous CIK cell immunotherapy has emerged as a safe and efficacious option to improve the prognosis of patients with high-risk DLBCL after the first CR." @default.
• W3036756141 created "2020-06-25" @default.
• W3036756141 creator A5009785946 @default.
• W3036756141 creator A5021428185 @default.
• W3036756141 creator A5023856133 @default.
• W3036756141 creator A5063691674 @default.
• W3036756141 creator A5081869985 @default.
• W3036756141 date "2020-06-01" @default.
• W3036756141 modified "2023-10-14" @default.
• W3036756141 title "<p>Autologous Cytokine-Induced Killer Cell Immunotherapy for Patients with High-Risk Diffuse Large B Cell Lymphoma After the First Complete Remission</p>" @default.
• W3036756141 cites W1886109881 @default.
• W3036756141 cites W1948158464 @default.
• W3036756141 cites W1983431609 @default.
• W3036756141 cites W1990424471 @default.
• W3036756141 cites W2032174355 @default.
• W3036756141 cites W2054059481 @default.
• W3036756141 cites W2061446068 @default.
• W3036756141 cites W2072351874 @default.
• W3036756141 cites W2072646319 @default.
• W3036756141 cites W2087362460 @default.
• W3036756141 cites W2130997237 @default.
• W3036756141 cites W2133114658 @default.
• W3036756141 cites W2141200671 @default.
• W3036756141 cites W2156661621 @default.
• W3036756141 cites W2167556523 @default.
• W3036756141 cites W2523392153 @default.
• W3036756141 cites W2605767476 @default.
• W3036756141 cites W2611096344 @default.
• W3036756141 cites W2624250607 @default.
• W3036756141 cites W2771658548 @default.
• W3036756141 cites W2784686711 @default.
• W3036756141 cites W2785013949 @default.
• W3036756141 cites W2801923213 @default.
• W3036756141 cites W2942989498 @default.
• W3036756141 cites W4385986623 @default.
• W3036756141 doi "https://doi.org/10.2147/ott.s254291" @default.
• W3036756141 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7319512" @default.
• W3036756141 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32606798" @default.
• W3036756141 hasPublicationYear "2020" @default.
• W3036756141 type Work @default.
• W3036756141 sameAs 3036756141 @default.
• W3036756141 citedByCount "2" @default.
• W3036756141 countsByYear W30367561412021 @default.
• W3036756141 crossrefType "journal-article" @default.
• W3036756141 hasAuthorship W3036756141A5009785946 @default.
• W3036756141 hasAuthorship W3036756141A5021428185 @default.
• W3036756141 hasAuthorship W3036756141A5023856133 @default.
• W3036756141 hasAuthorship W3036756141A5063691674 @default.
• W3036756141 hasAuthorship W3036756141A5081869985 @default.
• W3036756141 hasBestOaLocation W30367561411 @default.
• W3036756141 hasConcept C114684123 @default.
• W3036756141 hasConcept C126322002 @default.
• W3036756141 hasConcept C137061746 @default.
• W3036756141 hasConcept C143998085 @default.
• W3036756141 hasConcept C167672396 @default.
• W3036756141 hasConcept C202751555 @default.
• W3036756141 hasConcept C203014093 @default.
• W3036756141 hasConcept C2777701055 @default.
• W3036756141 hasConcept C2777761686 @default.
• W3036756141 hasConcept C2778559949 @default.
• W3036756141 hasConcept C2779109515 @default.
• W3036756141 hasConcept C2779338263 @default.
• W3036756141 hasConcept C55493867 @default.
• W3036756141 hasConcept C71924100 @default.
• W3036756141 hasConcept C86803240 @default.
• W3036756141 hasConcept C8891405 @default.
• W3036756141 hasConcept C90924648 @default.
• W3036756141 hasConceptScore W3036756141C114684123 @default.
• W3036756141 hasConceptScore W3036756141C126322002 @default.
• W3036756141 hasConceptScore W3036756141C137061746 @default.
• W3036756141 hasConceptScore W3036756141C143998085 @default.
• W3036756141 hasConceptScore W3036756141C167672396 @default.
• W3036756141 hasConceptScore W3036756141C202751555 @default.
• W3036756141 hasConceptScore W3036756141C203014093 @default.
• W3036756141 hasConceptScore W3036756141C2777701055 @default.
• W3036756141 hasConceptScore W3036756141C2777761686 @default.
• W3036756141 hasConceptScore W3036756141C2778559949 @default.
• W3036756141 hasConceptScore W3036756141C2779109515 @default.
• W3036756141 hasConceptScore W3036756141C2779338263 @default.
• W3036756141 hasConceptScore W3036756141C55493867 @default.
• W3036756141 hasConceptScore W3036756141C71924100 @default.
• W3036756141 hasConceptScore W3036756141C86803240 @default.
• W3036756141 hasConceptScore W3036756141C8891405 @default.
• W3036756141 hasConceptScore W3036756141C90924648 @default.
• W3036756141 hasLocation W30367561411 @default.
• W3036756141 hasLocation W30367561412 @default.
• W3036756141 hasLocation W30367561413 @default.
• W3036756141 hasLocation W30367561414 @default.
• W3036756141 hasOpenAccess W3036756141 @default.
• W3036756141 hasPrimaryLocation W30367561411 @default.
• W3036756141 hasRelatedWork W1506984959 @default.
• W3036756141 hasRelatedWork W1996150995 @default.
• W3036756141 hasRelatedWork W2002606273 @default.
• W3036756141 hasRelatedWork W2056385328 @default.
• W3036756141 hasRelatedWork W2149871822 @default.
• W3036756141 hasRelatedWork W2298085648 @default.
• W3036756141 hasRelatedWork W2371131850 @default.
• W3036756141 hasRelatedWork W2375391045 @default.

• next